PD-1-IN-17 free base is a small molecule composed of heteroaromatic and aliphatic units designed to support interaction studies with biomolecular targets. Researchers use it to evaluate ligand-binding geometry, conformational states, and solvation effects. Its structural diversity facilitates mechanistic modeling. The free-base form assists in versatile analytical handling.
CAT No: R2274
CAS No:1673560-66-1
Synonyms/Alias:1673560-66-1;PD-1-IN-17;PD1-IN-1;PD-1-IN-17 free base;(2S)-2-[[(1S)-4-amino-1-[5-[(1S,2R)-1-amino-2-hydroxypropyl]-1,3,4-oxadiazol-2-yl]-4-oxobutyl]carbamoylamino]-3-hydroxypropanoic acid;(S)-2-(3-((S)-4-Amino-1-(5-((1S,2R)-1-amino-2-hydroxypropyl)-1,3,4-oxadiazol-2-yl)-4-oxobutyl)ureido)-3-hydroxypropanoic acid;CHEMBL4458504;SCHEMBL19450456;EX-A4358;PD-1-IN-17?;AKOS040733979;AC-37062;DA-56651;MS-26046;HY-101097;CS-0020822;G16430;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More